Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas

Senate Committee on Federal and State Affairs

1 Min Read

Feb 20, 2017


Sarah M. Hartsig, M.S.


On February 20, 2017, Sarah M. Hartsig, M.S., KHI Senior Analyst, provided neutral testimony on Senate Bill 155 to the Senate Committee on Federal and State Affairs. The bill would, among other things, legalize medical marijuana for a variety of medical conditions.

During the testimony, KHI discussed findings and recommendations from its 2015 health impact assessment (HIA) Potential Health Effects of Legalizing Medical Marijuana in Kansas.

Access these publications in the Documents & Downloads section.

About Kansas Health Institute

The Kansas Health Institute supports effective policymaking through nonpartisan research, education and engagement. KHI believes evidence-based information, objective analysis and civil dialogue enable policy leaders to be champions for a healthier Kansas. Established in 1995 with a multiyear grant from the Kansas Health Foundation, KHI is a nonprofit, nonpartisan educational organization based in Topeka.

Learn More About KHI